HROW Q3 2017 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q3 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$6M+33.4% YoY

Gross Profit

$3M47.5% margin

Operating Income

-$3M-42.6% margin

Net Income

-$6M-87.8% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

-5.5%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$648,000

Balance Sheet

Total Assets

$26M

Total Liabilities

$22M

Stockholders' Equity

$4M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$5M	+33.4%
Gross Profit	$3M	$3M	+22.1%
Operating Income	-$3M	-$5M	+40.1%
Net Income	-$6M	-$4M	-47.8%